These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 14530573)

  • 1. The Janus face of glial-derived S100B: beneficial and detrimental functions in the brain.
    Van Eldik LJ; Wainwright MS
    Restor Neurol Neurosci; 2003; 21(3-4):97-108. PubMed ID: 14530573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neurotrophic protein S100B: value as a marker of brain damage and possible therapeutic implications.
    Kleindienst A; Hesse F; Bullock MR; Buchfelder M
    Prog Brain Res; 2007; 161():317-25. PubMed ID: 17618987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100B in brain damage and neurodegeneration.
    Rothermundt M; Peters M; Prehn JH; Arolt V
    Microsc Res Tech; 2003 Apr; 60(6):614-32. PubMed ID: 12645009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visualization of S100B-positive neurons and glia in the central nervous system of EGFP transgenic mice.
    Vives V; Alonso G; Solal AC; Joubert D; Legraverend C
    J Comp Neurol; 2003 Mar; 457(4):404-19. PubMed ID: 12561079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100B in neuropathologic states: the CRP of the brain?
    Sen J; Belli A
    J Neurosci Res; 2007 May; 85(7):1373-80. PubMed ID: 17348038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100B in schizophrenic psychosis.
    Rothermundt M; Ponath G; Arolt V
    Int Rev Neurobiol; 2004; 59():445-70. PubMed ID: 15006498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100B expression defines a state in which GFAP-expressing cells lose their neural stem cell potential and acquire a more mature developmental stage.
    Raponi E; Agenes F; Delphin C; Assard N; Baudier J; Legraverend C; Deloulme JC
    Glia; 2007 Jan; 55(2):165-77. PubMed ID: 17078026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the branched-chain alpha-keto acids accumulating in maple syrup urine disease on S100B release from glial cells.
    Funchal C; Tramontina F; Quincozes dos Santos A; Fraga de Souza D; Gonçalves CA; Pessoa-Pureur R; Wajner M
    J Neurol Sci; 2007 Sep; 260(1-2):87-94. PubMed ID: 17499767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100B in schizophrenia: an update.
    Rothermundt M; Ahn JN; Jörgens S
    Gen Physiol Biophys; 2009; 28 Spec No Focus():F76-81. PubMed ID: 20093730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100B content and secretion decrease in astrocytes cultured in high-glucose medium.
    Nardin P; Tramontina F; Leite MC; Tramontina AC; Quincozes-Santos A; de Almeida LM; Battastini AM; Gottfried C; Gonçalves CA
    Neurochem Int; 2007 Apr; 50(5):774-82. PubMed ID: 17350141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of neuron-specific enolase and S100B with histological cerebral damage in fetal sheep after severe asphyxia.
    Fujii EY; Kozuki M; Mu J; Ino Y; Ushioda N; Tomimatsu T; Fukuda H; Kanzaki T; Nakayama M; Murata Y
    Brain Res; 2004 Aug; 1018(1):136-40. PubMed ID: 15262215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100B protein is released by in vitro trauma and reduces delayed neuronal injury.
    Willoughby KA; Kleindienst A; Müller C; Chen T; Muir JK; Ellis EF
    J Neurochem; 2004 Dec; 91(6):1284-91. PubMed ID: 15584905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The S100B protein in biological fluids: more than a lifelong biomarker of brain distress.
    Michetti F; Corvino V; Geloso MC; Lattanzi W; Bernardini C; Serpero L; Gazzolo D
    J Neurochem; 2012 Mar; 120(5):644-59. PubMed ID: 22145907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased susceptibility of S100B transgenic mice to perinatal hypoxia-ischemia.
    Wainwright MS; Craft JM; Griffin WS; Marks A; Pineda J; Padgett KR; Van Eldik LJ
    Ann Neurol; 2004 Jul; 56(1):61-7. PubMed ID: 15236402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced calcium transients in glial cells in neonatal cerebellar cultures derived from S100B null mice.
    Xiong Z; O'Hanlon D; Becker LE; Roder J; MacDonald JF; Marks A
    Exp Cell Res; 2000 Jun; 257(2):281-9. PubMed ID: 10837142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental changes in content of glial marker proteins in rats exposed to protein malnutrition.
    Feoli AM; Leite MC; Tramontina AC; Tramontina F; Posser T; Rodrigues L; Swarowsky A; Quincozes-Santos A; Leal RB; Gottfried C; Perry ML; Gonçalves CA
    Brain Res; 2008 Jan; 1187():33-41. PubMed ID: 18021757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100B protein is released from rat neonatal neurons, astrocytes, and microglia by in vitro trauma and anti-S100 increases trauma-induced delayed neuronal injury and negates the protective effect of exogenous S100B on neurons.
    Ellis EF; Willoughby KA; Sparks SA; Chen T
    J Neurochem; 2007 Jun; 101(6):1463-70. PubMed ID: 17403138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical analysis of the role of the neurotrophic protein S100B in acute brain injury.
    Kleindienst A; Ross Bullock M
    J Neurotrauma; 2006 Aug; 23(8):1185-200. PubMed ID: 16928177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a wide extra-astrocytic distribution of S100B in human brain.
    Steiner J; Bernstein HG; Bielau H; Berndt A; Brisch R; Mawrin C; Keilhoff G; Bogerts B
    BMC Neurosci; 2007 Jan; 8():2. PubMed ID: 17199889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: a morphometric study.
    Steiner J; Bernstein HG; Bielau H; Farkas N; Winter J; Dobrowolny H; Brisch R; Gos T; Mawrin C; Myint AM; Bogerts B
    J Psychiatr Res; 2008 Aug; 42(10):868-76. PubMed ID: 18001771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.